Eurofins Scientific SE
ERFSFOTCHealthcare● Active
$72.60
$-3.39(-4.46%)
Market Cap$12.7B
P/E Ratio—
52W High$86.2
52W Low$63.96
Eurofins Scientific SE（ERFSF）· 现金流量表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · ERFSF · 截至 2026-06-10
财务报表
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | $0.47B | $0.55B | $0.31B | $0.78B | $1.06B |
| Depreciation & Amort. | $0.63B | $0.60B | $0.66B | $0.50B | $0.45B |
| Stock-Based Comp. | $0.00B | $0.14B | $0.14B | $0.14B | $0.13B |
| Change in Working Capital | $0.05B | $0.05B | ($0.03B) | $0.03B | ($0.01B) |
| Net Cash from Operations | $1.29B | $1.32B | $1.02B | $1.14B | $1.51B |
| Investing Activities | |||||
| Capital Expenditure | ($0.76B) | ($0.53B) | ($0.55B) | ($0.66B) | ($0.52B) |
| Purchases of Investments | $0.00B | $0.00B | $0.00B | ($0.00B) | ($0.01B) |
| Sales of Investments | $0.00B | $0.00B | $0.00B | $0.00B | $0.01B |
| Net Cash from Investing | ($1.09B) | ($0.85B) | ($0.68B) | ($0.86B) | ($1.03B) |
| Financing Activities | |||||
| Common Stock Repurchased | ($0.94B) | ($0.27B) | ($0.06B) | ($0.02B) | ($0.00B) |
| Dividends Paid | ($0.11B) | ($0.10B) | ($0.23B) | ($0.19B) | ($0.13B) |
| Debt Issued / Repaid | $0.91B | ($0.36B) | $0.55B | $0.38B | ($0.45B) |
| Net Cash from Financing | $0.01B | ($1.09B) | $0.41B | ($0.31B) | ($0.91B) |
| Free Cash Flow | |||||
| Free Cash Flow | $0.53B | $0.79B | $0.47B | $0.48B | $0.99B |
| FCF Margin %(computed) | 7.33% | 11.37% | 7.18% | 7.09% | 14.74% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · EUR · B
深入了解Eurofins Scientific SE
关于Eurofins Scientific SE（ERFSF）现金流量表
Eurofins Scientific SE 2025财年经营活动现金流$1.29B，自由现金流$0.53B（FCF利润率7.33%），资本支出($0.76B)。
常见问题
ERFSF · 4 问Eurofins Scientific SE 2025财年自由现金流$0.53B，同比down32.3%。
ERFSF free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10